|
Joel Kupersmith, MD
Chief Research and Development Officer (CRADO)
Dr. Kupersmith is a graduate of New York Medical College where he also completed his clinical residency in internal medicine. Subsequently, he completed a cardiology fellowship at Beth Israel Medical Center/Harvard Medical School. After research training in the Department of Pharmacology, Columbia College of Physicians and Surgeons, he joined the faculty of the Mt. Sinai School of Medicine where he rose to the rank of Professor and was Director of the Clinical Pharmacology section. After this he became Chief of Cardiology and V.V. Cooke Professor of Medicine at the University of Louisville and then Professor and Chairperson, Department of Medicine at the College of Human Medicine at Michigan State University.
Dr. Kupersmith then became Dean, School of Medicine and Graduate School of Biomedical Sciences, Vice President for Clinical Affairs at Texas Tech University as well as CEO of the Faculty Practice. In this position there were many advances in the medical center including a comprehensive strategic plan; a marked stepwise drop in faculty attrition rate; legislative initiatives; growth of the research enterprise; important recruitments; many educational initiatives; construction projects; improved scores of entering students and increased number of minority students. In addition, Dr. Kupersmith had an early role in the process to establish a new medical school in El Paso, Texas.
Subsequently, Dr. Kupersmith was a Scholar-in-Residence at both the Institute of Medicine and the Association of American Medical Colleges before assuming duties as Chief Research and Development Officer of the VA. In these roles he completed projects and published papers on a number of health and research policy projects including how to fund, oversee and promote effectiveness research, how Academic Medical Centers should be accountable, quality of care in teaching hospitals, regional IRBs, medical manpower and other issues.
Dr. Kupersmith has 150 publications and two books. His earlier research interests were in the area of electrophysiology, the causes and treatment of heart rhythm abnormalities and implantable cardioverter defibrillators. His work included delineation of conduction system characteristics in the human heart, unique effects of antiarrhythmic drugs in ischemic tissue as a basis for their antiarrhythmic actions and classification and electrophysiologic consequences of the sodium/potassium pump. Subsequently, he published in the area of cost effectiveness of heart disease treatments and outcomes following heart attacks. Most recently his work has been on health policy issues.
Dr. Kupersmith has been on many national and international committees involved in heart disease and on editorial boards of the American Journal of Medicine and two heart disease journals. He is a member of numerous professional organizations including the American Society for Clinical Investigation. Dr. Kupersmith is a winner of an Affirmative Action Award from the University of Louisville and an Alumni Association distinguished achievement award from New York Medical College. Dr. Kupersmith has also been a Visiting Scholar at the Hastings Center for ethics. He is listed in Who's Who in America and several others.
Dr. Kupersmith was elected to the Governing Council, Medical School Section of the American Medical Association, is a member of the Association of American Medical Colleges Task Force on Fraud and Abuse, and has been a Site Visit Chair for the Liaison Committee on Medical Education.
|
